These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32220262)

  • 1. Corosolic Acid Inhibits Cancer Progress Through Inactivating YAP in Hepatocellular Carcinoma.
    Jia M; Xiong Y; Li M; Mao Q
    Oncol Res; 2020 Sep; 28(4):371-383. PubMed ID: 32220262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking inhibition to YAP by ActinomycinD enhances anti-tumor efficacy of Corosolic acid in treating liver cancer.
    Xu Y; Zhao Y; Xu Y; Guan Y; Zhang X; Chen Y; Wu Q; Zhu G; Chen Y; Sun F; Wang J; Yu Y
    Cell Signal; 2017 Jan; 29():209-217. PubMed ID: 27836738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.
    Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X
    Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma.
    Wu J; Chai H; Li F; Ren Q; Gu Y
    Life Sci; 2020 Nov; 260():118406. PubMed ID: 32918976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
    Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
    Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway.
    Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL
    Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells.
    Dai XY; Zhuang LH; Wang DD; Zhou TY; Chang LL; Gai RH; Zhu DF; Yang B; Zhu H; He QJ
    Oncotarget; 2016 Feb; 7(6):6933-47. PubMed ID: 26771844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The membrane protein melanoma cell adhesion molecule (MCAM) is a novel tumor marker that stimulates tumorigenesis in hepatocellular carcinoma.
    Wang J; Tang X; Weng W; Qiao Y; Lin J; Liu W; Liu R; Ma L; Yu W; Yu Y; Pan Q; Sun F
    Oncogene; 2015 Nov; 34(47):5781-95. PubMed ID: 25728681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer.
    Wang J; Ma L; Weng W; Qiao Y; Zhang Y; He J; Wang H; Xiao W; Li L; Chu Q; Pan Q; Yu Y; Sun F
    Hepatology; 2013 Sep; 58(3):1011-20. PubMed ID: 23532963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP activation is an early event and a potential therapeutic target in liver cancer development.
    Perra A; Kowalik MA; Ghiso E; Ledda-Columbano GM; Di Tommaso L; Angioni MM; Raschioni C; Testore E; Roncalli M; Giordano S; Columbano A
    J Hepatol; 2014 Nov; 61(5):1088-96. PubMed ID: 25010260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [YAP regulates the proliferation and modifies the sensitivity to sorafenib in hepatocellular carcinoma cells].
    Guo LW; Shao GL; Luo J; Hao WY; Yao Z; Zheng JP
    Zhonghua Zhong Liu Za Zhi; 2018 Nov; 40(11):818-823. PubMed ID: 30481931
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of hypoxia-induced YAP by statins overcomes hypoxic resistance tosorafenib in hepatocellular carcinoma cells.
    Zhou TY; Zhuang LH; Hu Y; Zhou YL; Lin WK; Wang DD; Wan ZQ; Chang LL; Chen Y; Ying MD; Chen ZB; Ye S; Lou JS; He QJ; Zhu H; Yang B
    Sci Rep; 2016 Aug; 6():30483. PubMed ID: 27476430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy.
    Xia H; Dai X; Yu H; Zhou S; Fan Z; Wei G; Tang Q; Gong Q; Bi F
    Cell Death Dis; 2018 Feb; 9(3):269. PubMed ID: 29449645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of yes-associated protein inhibits proliferation and downregulates large tumor suppressor 1 expression in MHCC97H human hepatocellular carcinoma cells.
    Wang C; Zhu ZM; Liu CL; He XJ; Zhang HY; Dong JH
    Mol Med Rep; 2015 Jun; 11(6):4101-8. PubMed ID: 25625370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenic role of YAP in hepatocellular carcinogenesis is involved in SHP2 whose function is different in vitro and in vivo.
    Kim MK; Park JY; Kang YN
    Pathol Res Pract; 2018 Jul; 214(7):1031-1039. PubMed ID: 29699904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Yes-associated protein confers doxorubicin resistance in hepatocellullar carcinoma.
    Huo X; Zhang Q; Liu AM; Tang C; Gong Y; Bian J; Luk JM; Xu Z; Chen J
    Oncol Rep; 2013 Feb; 29(2):840-6. PubMed ID: 23232767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway.
    Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B
    Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIZ1 interacts with YAP and activates its transcriptional activity in hepatocellular carcinoma cells.
    Lei L; Wu J; Gu D; Liu H; Wang S
    Tumour Biol; 2016 Aug; 37(8):11073-9. PubMed ID: 26906552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.